PACB
PACB
US69404D1081
Pacific Biosciences of Californ
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 160.005.000 154.014.000
3.9%
Cost of Revenue 114.225.000 116.732.000
2.1%
Gross Profit 45.780.000 37.282.000
22.8%
603.341.000 327.945.000
84.0%
Operating Income -557.561.000 -290.663.000
91.8%
Pretax Income -546.058.000 -309.535.000
76.4%
Net Income Common Stockholders -546.376.000 -309.851.000
76.3%
-- --
--
-- --
--
ende